Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hemoglobin determination + NaCl 0.9% bolus
- Development stage
- Preclinical
- Lead developer
- University Medical Center Groningen
- Modality
- Small Molecules
- Administration
- Intravenous
01
Overview
Hemoglobin determination + NaCl 0.9% bolus is a clinical trial intervention arm evaluated by the University Medical Center Groningen in patients undergoing elective hepatic resection. This intervention combines invasive hemoglobin determination (blood sampling) with the administration of a 0.9% sodium chloride (normal saline) fluid bolus. It was utilized in a clinical study (NCT01060683) to investigate the accuracy and reliability of continuous non-invasive hemoglobin monitoring (SpHb) via pulse co-oximetry during acute hemodilution caused by rapid fluid expansion.
- Other names
- hemoglobin determination + NaCl 0.9% bolushemoglobin determination + sodium chloride 0.9% bolus
Beyond the preview
Go deeper on Hemoglobin determination + NaCl 0.9% bolus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hemoglobin determination + NaCl 0.9% bolus.